COVID-19 as a Catalyst for the Adoption of Real-World Evidence

November 24, 2020

Dr. Scott Gottlieb, Former Commissioner of the Food and Drug Administration speaks with Parexel’s Peyton Howell, Executive Vice President, Chief Commercial & Strategy Officer and Sy Pretorius, Executive Vice President, Chief Medical & Scientific Officer about the evolving role of RWE.

Previous Article
2020: A Strong Year for New Drug Therapy Approvals – Despite Many COVID-19 Challenges
2020: A Strong Year for New Drug Therapy Approvals – Despite Many COVID-19 Challenges

In 2020, we approved a wide variety of new drugs never before marketed in the United States, known as "nove...

Next Article
EMA recommends COVID-19 Vaccine Moderna for authorisation in the EU , , 06/01/2021

COVID-19 Vaccine Moderna is now authorised across the EU. This follows the granting of a conditional market...